How can oral health care providers determine if patients have dry mouth?

Journal of the American Dental Association

Volumn 134, Issue 5, 2003, Pages 613-618

  Navazesh, Mahvash ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; CLINICAL FEATURE; DENTAL CARIES; DENTAL HEALTH; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; EARLY DIAGNOSIS; HUMAN; HYPOSALIVATION; INFECTION COMPLICATION; INFECTION PREVENTION; PATHOPHYSIOLOGY; REVIEW; SALIVARY GLAND BIOPSY; SALIVATION; XEROSTOMIA; ARTICLE; BIOPSY; PATHOLOGY; QUESTIONNAIRE; SALIVA; SALIVARY GLAND; SECRETION;

BIOPSY; HUMANS; MEDICAL HISTORY TAKING; QUESTIONNAIRES; SALIVA; SALIVARY GLANDS; XEROSTOMIA;

EID: 0038672753     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2003.0229     Document Type: Review

References (47)

1. Guggenheimer J, Moore P. Xerostomia: etiology, recognition and treatment. JADA 2003;134:61-9.
2. Mestel R. The wonders of saliva. Los Angeles Times Jan. 21, 2002:S1.
3. Thompson SD, Watkins CA, Warren JJ, Qian F, Dawson DV. Dry mouth and oral diseases in 79+ elders. J Dent Res 2002;81 (abstract 0986):A-143.
4. Navazesh M, Denny P, Sobel S. Saliva: a fountain of opportunity. J Calif Dent Assoc 2002;30:783-8.
5. Nedefors T. Xerostomia and hyposalivation. Adv Dent Res 2000;14:48-56.
6. Mulligan R, Navazesh M, Komaroff E. Salivary gland disease in human immunodeficiency virus-positive women from the WIHS study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:702-9.
7. Navazesh M, Mulligan R, Komaroff E, Redford M, Greenspan D, Phelan J. The prevalence of xerostomia and salivary gland hypofunction in a cohort of HIV-positive and at-risk women. J Dent Res 2000;79:1502-7.
8. Nusair S, Rubinow A. The use of oral pilocarpine in xerostomia and Sjögren's syndrome. Semin Arthritis Rheum 1999;28:360-7.
9. Nagler RM, Nagler A. Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study. Bone Marrow Transplant 1999;23:1007-11.
10. Narhi TO, Meurman JH, Ainamo A. Xerostomia and hyposalivation: causes, consequences and treatment in the elderly. Drugs Aging 1999;15:103-16.
11. Astor FC, Hanft KL, Ciocon JO. Xerostomia: a prevalent condition in the elderly. Ear Nose Throat J 1999;78:476-9.
12. Vissink A, Spijkervet FK, Van Nieuw Amerongen A. Aging and saliva: a review of the literature. Spec Care Dentist 1996;16(3):95-103.
13. Narhi TO. Prevalence of subjective feelings of dry mouth in the elderly. J Dent Res 1994;73(1):20-5.
14. Johnson JT, Ferretti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993;329:390-5.
15. Wright WE, Haller JM, Harlow SA, Pizzo PA. An oral disease prevention program for patients receiving radiation and chemotherapy. JADA 1985;110:43-7.
16. Amerongen AN, Veerman EC. Saliva: the defender of the oral cavity. Oral Dis 2002;8(1):12-22.
17. Torres SR, Peixoto CB, Caldas DM, et al. Relationship between salivary flow rates and Candida counts in subjects with xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:149-54.
18. Lenander-Lumikari M, Loimaranta V. Saliva and dental caries. Adv Dent Res 2000;14:40-7.
19. Umazume M, Ueta E, Osaki T. Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy. J Clin Microbiol 1995;33(2):432-9.
20. Loesche WJ, Bromberg J, Terpenning MS, et al. Xerostomia, xerogenic medications and food avoidance in selected geriatric groups. J Am Geriatr Soc 1995;43:401-7.
21. Papas AS, Joshi A, MacDonald SL, Maravelis-Splagounias L, Pretara-Spanedda P, Curro FA. Caries prevalence in xerostomic individuals. J Can Dent Assoc 1993;59(2):171-9.
22. Gibson G, Barrett E. The role of salivary function on oropharyngeal colonization. Spec Care Dentist 1992;12(4):153-6.
23. Osterberg T, Landahl S, Hedegard B. Salivary flow, saliva, pH and buffering capacity in 70-year-old men and women: correlation to dental health, dryness in the mouth, disease and drug treatment. J Oral Rehab 1984;11:157-70.
24. Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective measures of salivary gland performance. JADA 1987;115:581-4.
25. Pai S, Ghezzi EM, Ship JA. Development of a visual analogue scale questionnaire for subjective assessment of salivary dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:311-6.
26. Campbell WI, Patterson CC. Quantifying meaningful changes in pain. Anaesthesia 1998;53:121-5.
27. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983;17:45-56.
28. Little JW. Eating disorders: dental implications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:138-43.
29. Slavkin HC. Distinguishing Mars from Venus: emergence of gender biology differences in oral health and systemic disease. Compendium 2002;23:29-31.
30. Younai FS, Marcus M, Freed JR, et al. Self-reported oral dryness and HIV disease in a national sample of patients receiving medical care. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:629-36.
31. Pajukoski H, Meurman JH, Halonen P, Sulkava R. Prevalence of subjective dry mouth and burning mouth in hospitalized elderly patients and outpatients in relation to saliva, medication, and systemic diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:641-9.
32. Navazesh M, Brightman VJ, Pogoda JM. Relationship of medical status, medications, and salivary flow rates in adults of different ages. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;81:172-6.
33. Bergdahl M, Bergdahl J. Low unstimulated salivary flow and subjective oral dryness: association with medication, anxiety, depression, and stress. J Dent Res 2000;79:1652-8.
34. Sreebny LM, Valdini A, Yu A. Xerostomia, part II: relationship to nonoral symptoms, drugs and diseases. Oral Surg Oral Med Oral Pathol 1989;68:419-27.
35. Sreebny LM, Valdini A. Xerostomia, part I: relationship to other oral symptoms and salivary gland hypofunction. Oral Surg Oral Med Oral Pathol 1988;66:451-8.
36. Oxholm P, Asmussen K. Primary Sjögren's syndrome: the challenge for classification of disease manifestations. J Intern Med 1996;239:467-74.
37. Navazesh M, Christensen CM, Brightman VJ. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 1992;71:1363-9.
38. Ship J, Fox PC, Baum BJ. How much saliva is enough? 'Normal' function defined. JADA 1991;122:63-9.
39. Khurshudian AV. A pilot study to test the efficacy of oral administration of interferon-α lozenges to patients with Sjögren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:38-44.
40. Yasuda H, Niki H. Review of the pharmacological properties and clinical usefulness of muscarinic agonists for xerostomia in patients with Sjögren's syndrome. Clin Drug Invest 2002;22(2):67-73.
41. Ship JA. Diagnosing, managing, and preventing salivary gland disorders. Oral Dis 2002;8:77-89.
42. Ship JA, Pillemer SR, Baum BJ. Xerostomia and the geriatric patient. J Am Geriatr Soc 2002;50:535-43.
43. Navazesh M. Dry mouth: aging and oral health. Compendium 2002;23:41-8.
44. Artificial salivas. JADA 2001;132:1720-1.
45. Daniels TE, Wu AJ. Xerostomia: clinical evaluation and treatment in general practice. J Calif Dent Assoc 2000;28:933-41.
46. Ship JA, Fischer DJ. The relationship between dehydration and parotid salivary gland function in young and older healthy adults. J Gerontol Med Sci 1997;52:M310-9.
47. Atkinson JC, Fox PC. Sjögren's syndrome: oral and dental considerations. JADA 1993;124(3):74-86.